226 related articles for article (PubMed ID: 23711808)
1. Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy.
Liu W; Liu W; Hu D; Zhu T; Ma Z; Yang J; Xie W; Li C; Li L; Yang J; Li T; Bian H; Tong Q
Am J Cardiol; 2013 Aug; 112(4):585-9. PubMed ID: 23711808
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study.
Mattos BP; Scolari FL; Torres MA; Simon L; Freitas VC; Giugliani R; Matte Ú
Arq Bras Cardiol; 2016 Sep; 107(3):257-265. PubMed ID: 27737317
[TBL] [Abstract][Full Text] [Related]
3. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
[TBL] [Abstract][Full Text] [Related]
4. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
[TBL] [Abstract][Full Text] [Related]
5. [Mutation and clinical relevance in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy].
Jie L; Wenling L; Dayi H; Tiangang Z; Wen L; Zhanfeng M; Jie Y; Wenli X; Cuilan L; Lei L; Guozhong P
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):682-9. PubMed ID: 26955724
[TBL] [Abstract][Full Text] [Related]
6. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of MYH7, MYBPC3 and TNNT2 gene mutations in 10 Chinese pedigrees with familial hypertrophic cardiomyopathy and the correlation between genotype and phenotype].
Liu WL; Xie WL; Hu DY; Zhu TG; Li YT; Sun YH; Li CL; Li L; Li TC; Bian H; Tong QG; Yang SN; Fan RY; Cui W
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):202-7. PubMed ID: 16630449
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients.
García-Castro M; Reguero JR; Batalla A; Díaz-Molina B; González P; Alvarez V; Cortina A; Cubero GI; Coto E
Clin Chem; 2003 Aug; 49(8):1279-85. PubMed ID: 12881443
[TBL] [Abstract][Full Text] [Related]
10. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
Chiou KR; Chu CT; Charng MJ
J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of gene mutation between Chinese patients with familial and sporadic hypertrophic cardiomyopathy].
Pan GZ; Liu WL; Hu DY; Xie WL; Zhu TG; Li L; Li CL; Bian H
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2998-3001. PubMed ID: 17288815
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy.
Otsuka H; Arimura T; Abe T; Kawai H; Aizawa Y; Kubo T; Kitaoka H; Nakamura H; Nakamura K; Okamoto H; Ichida F; Ayusawa M; Nunoda S; Isobe M; Matsuzaki M; Doi YL; Fukuda K; Sasaoka T; Izumi T; Ashizawa N; Kimura A
Circ J; 2012; 76(2):453-61. PubMed ID: 22112859
[TBL] [Abstract][Full Text] [Related]
13. [The genotype-phenotype correlation of MYH7 gene G15391A mutation and MYBPC3 gene G12101A mutation in familial hypertrophic cardiomyopathy].
WANG H; ZOU YB; WANG JZ; SONG L; SUN K; SONG XD; WANG XJ; ZHANG CN; HUI RT
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1059-62. PubMed ID: 19134269
[TBL] [Abstract][Full Text] [Related]
14. Myocardial Deformation Analysis in
Höller V; Seebacher H; Zach D; Schwegel N; Ablasser K; Kolesnik E; Gollmer J; Waltl G; Rainer PP; Verheyen S; Zirlik A; Verheyen N
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680864
[TBL] [Abstract][Full Text] [Related]
15. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
[TBL] [Abstract][Full Text] [Related]
17. Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy.
Biagini E; Olivotto I; Iascone M; Parodi MI; Girolami F; Frisso G; Autore C; Limongelli G; Cecconi M; Maron BJ; Maron MS; Rosmini S; Formisano F; Musumeci B; Cecchi F; Iacovoni A; Haas TS; Bacchi Reggiani ML; Ferrazzi P; Salvatore F; Spirito P; Rapezzi C
Am J Cardiol; 2014 Sep; 114(5):769-76. PubMed ID: 25037680
[TBL] [Abstract][Full Text] [Related]
18. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
[TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
[TBL] [Abstract][Full Text] [Related]
20. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy.
Erdmann J; Daehmlow S; Wischke S; Senyuva M; Werner U; Raible J; Tanis N; Dyachenko S; Hummel M; Hetzer R; Regitz-Zagrosek V
Clin Genet; 2003 Oct; 64(4):339-49. PubMed ID: 12974739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
